The ARK Genomic Revolution ETF's ("Fund") investment objective is long -term growth of capital.
| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | TEMPUS AI INC CL A | — | 9.4203% |
| 2 | TWIST BIOSCIENCE CORP COM | — | 8.9885% |
| 3 | CRISPR THERAPEUTICS AG NAMEN AKT | — | 8.9093% |
| 4 | 10X GENOMICS INC CL A COM | — | 5.7674% |
Last synced Sep 10, 2026, 6:25 AM · Price and AUM from Yahoo Finance · Holdings from SEC N-PORT filings
| 5 | BEAM THERAPEUTICS INC COM | — | 5.4289% |
| 6 | ABSCI CORP COM | — | 4.7808% |
| 7 | NATERA INC COM | — | 4.0655% |
| 8 | ILLUMINA INC COM | — | 4.0286% |
| 9 | INTELLIA THERAPEUTICS INC COM | — | 3.8158% |
| 10 | PERSONALIS INC COM | — | 3.5809% |
| 11 | RECURSION PHARMACEUTICALS INC CL A | — | 3.5133% |
| 12 | GUARDANT HEALTH INC COM | — | 3.4948% |
| 13 | CAREDX INC COM | — | 3.3841% |
| 14 | VERACYTE INC COM | — | 2.6636% |
| 15 | COMPASS PATHWAYS PLC SPONSORED ADS | — | 2.4310% |
| 16 | ADAPTIVE BIOTECHNOLOGIES CORP COM | — | 2.4228% |
| 17 | NURIX THERAPEUTICS INC COM | — | 2.3292% |
| 18 | GENEDX HOLDINGS CORP COM CL A | — | 2.0421% |
| 19 | SCHRODINGER INC COM | — | 2.0257% |
| 20 | ARCTURUS THERAPEUTICS HOLDINGS INC COM | — | 1.9593% |
| 21 | BUTTERFLY NETWORK INC COM CL A | — | 1.8949% |
| 22 | IONIS PHARMACEUTICALS INC COM | — | 1.7436% |
| 23 | ATAIBECKLEY INC COM SHS | — | 1.4752% |
| 24 | PRIME MEDICINE INC COM | — | 1.4129% |
| 25 | PACIFIC BIOSCIENCES OF CALIFORNIA INC COM | — | 1.4107% |
| 26 | CERUS CORP COM | — | 1.2238% |
| 27 | ALAMAR BIOSCIENCES INC COMMON STOCK | — | 1.2087% |
| 28 | 908 DEVICES INC COM | — | 1.0791% |
| 29 | BIONTECH SE SPONSORED ADS | — | 1.0625% |
| 30 | ELI LILLY & COMPANY COM | — | 0.9507% |
| 31 | QUANTUM-SI INC COM CL A | — | 0.5497% |
| 32 | GENERATE BIOMEDICINES INC COM SHS | — | 0.5146% |
| 33 | Goldman Sachs Financial Square Treasury Obligations Fund | — | 0.1280% |